SILVERARC CAPITAL MANAGEMENT LLC 13D and 13G filings for Mersana Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-15 06:55 am Sale | 2024-10-11 | 13G | Mersana Therapeutics, Inc. MRSN | SILVERARC CAPITAL MANAGEMENT LLC | 1,754,086 1.430% | -4,666,050 (-72.68%) | Filing |
| 2024-02-14 8:43 pm Purchase | 2023-12-31 | 13G | Mersana Therapeutics, Inc. MRSN | SILVERARC CAPITAL MANAGEMENT LLC | 6,420,136 5.300% | 6,420,136 (New Position) | Filing |